Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility
Margaret Wrensch(Neurological Surgery), Robert B. Jenkins(Mayo Clinic), Jeffrey S. Chang(University of California, San Francisco), Ru-Fang Yeh(University of California, San Francisco), Yuanyuan Xiao(University of California, San Francisco), Paul A. Decker(Mayo Clinic), Karla V. Ballman(Mayo Clinic), Mitchel S. Berger(University of California, San Francisco), Jan C. Buckner(Mayo Clinic), Susan M. Chang(University of California, San Francisco), Caterina Giannini(Mayo Clinic), Chandralekha Halder(Mayo Clinic), Thomas M. Kollmeyer(Mayo Clinic), Matthew Kosel(Mayo Clinic), Daniel H. Lachance(Mayo Clinic), Lucie McCoy(Neurological Surgery), Brian Patrick O’Neill(Mayo Clinic), Joe Patoka(Neurological Surgery), Alexander R. Pico(University of California, San Francisco), Michael D. Prados(Neurological Surgery), Charles P. Quesenberry(Kaiser Permanente), Terri Rice(University of California, San Francisco), Amanda L. Rynearson(Mayo Clinic), Ivan Smirnov(University of California, San Francisco), Tarık Tihan(University of California, San Francisco), Joe Wiemels(University of California, San Francisco), Ping Yang(Mayo Clinic), John K. Wiencke(Neurological Surgery)
Cited by 512Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis